Sanofi Signs Benitec's closest competitor Voyager for $845M

Sanofi embarks on an $845M gene therapy R&D odyssey with Voyager
February 11, 2015 | By John Carroll

Sanofi subsidiary Genzyme is tying up with gene therapy upstart Voyager Therapeutics, gambling $100 million upfront on the hot field and promising up to $745 million in milestones for their partnership on a full slate of development programs.

http://www.fiercebiotech.com/story/sanofi-embarks-845m-gene-therapy-odyssey-voyager/2015-02-11

Here's Dirk's blog from a year ago when his buddy and ex boss Mark Kay's new Co Voyager was announced :
http://rnaitherapeutics.blogspot.com.au/2014/02/voyager-therapeutics-sets-out-to.html